Today: 7 February 2026
Subscribe

PayPal stock slips in late trade as Wall Street wraps 2025; what investors watch next for PYPL

PayPal stock slips in late trade as Wall Street wraps 2025; what investors watch next for PYPL

NEW YORK, Dec 31, 2025, 6:41 PM ET — After-hours PayPal Holdings, Inc. (PYPL) shares were down 1.2% at $58.38 in after-hours trading on Wednesday, when stocks changed hands outside the regular 9:30 a.m. to 4 p.m. ET session. The stock traded between $58.30 and $59.21 and saw about 13.0 million shares in volume, with the shares valued at roughly 13 times trailing earnings, a standard price-to-earnings measure. The move matters now because liquidity typically dries up into the final session of the year, leaving even modest flows to move prices. Investors also use the calendar turn to reset exposure
1 January 2026
···
ServiceNow (NOW) stock slips after hours as CEO contract change nears and $7.75B Armis deal stays in focus

ServiceNow (NOW) stock slips after hours as CEO contract change nears and $7.75B Armis deal stays in focus

NEW YORK, December 31, 2025, 19:07 ET — After-hours ServiceNow shares fell 0.7% to $153.19 in after-hours trading on Wednesday, which takes place outside the regular 9:30 a.m. to 4 p.m. ET session. The stock’s late move followed a downbeat finish for Wall Street on the final trading day of 2025. The S&P 500 fell 0.7% and the Nasdaq dropped 0.8% in thin trading, with technology stocks the biggest drag, while the 10-year Treasury yield rose to 4.17%, AP reported. The Business Journal The timing matters because U.S. stock and bond markets are closed on Thursday for New Year’s Day,
1 January 2026
··
Axsome stock jumps nearly 23% after FDA fast-tracks AXS-05 for Alzheimer’s agitation

Axsome stock jumps nearly 23% after FDA fast-tracks AXS-05 for Alzheimer’s agitation

NEW YORK, December 31, 2025, 19:19 ET — After-hours Axsome Therapeutics, Inc. shares jumped 22.9% to $182.64 in after-hours trading on Wednesday after the company said the U.S. Food and Drug Administration accepted its supplemental New Drug Application for AXS-05 to treat agitation linked to Alzheimer’s disease and granted it Priority Review. The agency set an April 30, 2026 target action date, and CEO Herriot Tabuteau said “up to 76% of people with Alzheimer’s disease experience agitation.” GlobeNewswire The decision matters because Priority Review shortens the FDA’s review timeline, pulling a key regulatory catalyst forward for investors who have been
1 January 2026
···
Bank of America stock today: BAC slips after-hours as year-end selling and rate focus set up January catalysts

Bank of America stock today: BAC slips after-hours as year-end selling and rate focus set up January catalysts

NEW YORK, December 31, 2025, 19:01 ET — After-hours Bank of America shares dipped about 0.5% in after-hours trading on Wednesday, last near $55, after fluctuating between roughly $54.94 and $55.41 during the session. The year-end move matters because markets shut for New Year’s Day, giving investors a pause to reset expectations for rates and bank earnings before trading resumes in 2026. With the next round of big-bank results approaching, even small shifts in Treasury yields can move bank stocks because they influence lending margins and funding costs. In regular trading, Bank of America fell 0.5% to $55.00, alongside declines
1 January 2026
·
Sidus Space stock swings after-hours as $16.2 mln share sale and new 13G stake keep SIDU in focus

Sidus Space stock swings after-hours as $16.2 mln share sale and new 13G stake keep SIDU in focus

NEW YORK, December 31, 2025, 19:07 ET — After-hours Sidus Space Inc shares surged in year-end trading on Wednesday, closing up 31.9% at $3.52 and then sliding about 10.8% in after-hours to $3.14. The Nasdaq-listed stock ranged from $2.48 to $4.20 on the day as volume ran above 168 million shares. Yahoo Finance The sharp move matters because Sidus, like many early-stage space hardware and data companies, relies heavily on access to capital markets. When financing news hits, the stock can swing quickly as investors recalibrate near-term cash runway versus dilution. It also comes at a moment when traders are
1 January 2026
·
Salesforce stock slips after-hours to end 2025 as focus turns to Agentforce AI and Feb. 25 earnings

Salesforce stock slips after-hours to end 2025 as focus turns to Agentforce AI and Feb. 25 earnings

NEW YORK, December 31, 2025, 19:03 ET — After-hours Salesforce, Inc. shares ended down 0.4% on Wednesday and hovered near $264.91 in after-hours trading, as the cloud software maker closed out 2025’s final session on a subdued note. The stock traded between $264.44 and $266.12 during the session. The late drift underscored how thin year-end liquidity can magnify moves in large-cap technology names, even without fresh company news. For Salesforce, the timing matters because investors are resetting exposure ahead of 2026, when spending on enterprise software and new AI features is expected to be under sharper scrutiny. A Yahoo Finance
1 January 2026
···
Pfizer stock dips after-hours as 2026 drug price hike list puts PFE in the spotlight

Pfizer stock dips after-hours as 2026 drug price hike list puts PFE in the spotlight

NEW YORK, December 31, 2025, 18:50 ET — After-hours Pfizer Inc. shares fell about 0.4% to $24.90 in after-hours trading on Wednesday, after a report said the drugmaker is leading a wave of U.S. list-price increases set for 2026. The data, compiled by healthcare research firm 3 Axis Advisors, showed drugmakers plan hikes on at least 350 branded medicines, with Pfizer accounting for around 80 increases, including a 15% rise for its COVID vaccine Comirnaty. “They really just nibble around the margins,” said Dr. Benjamin Rome, a health policy researcher at Brigham and Women’s Hospital in Boston. Reuters The timing
1 January 2026
···
Cisco stock today: CSCO slips into the close as year-end trading thins, dividend date nears

Cisco stock today: CSCO slips into the close as year-end trading thins, dividend date nears

NEW YORK, December 31, 2025, 18:54 ET — After-hours Cisco Systems Inc shares slipped in the final trading session of 2025, closing down about 0.5% at $77.03 and holding steady in after-hours trading. The move came as Wall Street wrapped up the year with broad declines in thin holiday-week trade. The S&P 500 fell 0.74% and the Nasdaq dropped 0.76%, and U.S. markets are closed on Thursday for New Year’s Day, Reuters reported. “It’s perfectly fine in any bull market to have moments of cost,” said Giuseppe Sette, co-founder and president of Reflexivity, pointing to profit-taking when liquidity is low.
1 January 2026
··
GE Vernova stock slips after hours as 2025 ends; dividend date and January earnings in focus

GE Vernova stock slips after hours as 2025 ends; dividend date and January earnings in focus

NEW YORK, December 31, 2025, 18:41 ET — After-hours GE Vernova Inc. shares fell in after-hours trading on Wednesday, down 0.9% at $653.57 by 6:41 p.m. ET, or $6.19 below Tuesday’s close. The stock traded between $647.71 and $666.30 during the day, with about 1.26 million shares changing hands. The slide underscores how sensitive the stock has become to year-end positioning after a sharp run tied to rising electricity demand and data-center buildouts. GE Vernova’s shares have risen more than 370% since the company was spun off from General Electric in 2024, Reuters reported earlier this month. Reuters With U.S.
1 January 2026
···
Corcept stock plunges 50% after FDA rejects relacorilant in Cushing’s-related hypertension

Corcept stock plunges 50% after FDA rejects relacorilant in Cushing’s-related hypertension

NEW YORK, December 31, 2025, 18:31 ET — After-hours Corcept Therapeutics Inc shares sank about 50% in after-hours trading on Wednesday after the U.S. Food and Drug Administration declined to approve its oral drug relacorilant for a Cushing’s-related hypertension use. The stock was last at $34.80, down $35.39 from the prior close. Reuters The decision hits at a key moment for Corcept, which investors have looked to relacorilant to expand the company’s business beyond its marketed drug Korlym. A regulatory setback for relacorilant raises the risk that Corcept’s next growth driver takes longer—and costs more—to reach the market. Reuters Corcept
1 January 2026
··
Super Micro (SMCI) stock slips into year-end after SEC filing flags operations shake-up

Super Micro (SMCI) stock slips into year-end after SEC filing flags operations shake-up

NEW YORK, December 31, 2025, 18:49 ET — After-hours Super Micro Computer shares slid on Wednesday in thin year-end trading, as investors weighed a leadership change disclosed in a regulatory filing and a broader pullback in technology stocks. The move matters because Super Micro’s valuation has remained tightly tied to confidence in execution — shipping high-end server systems on time while managing margins in a competitive AI hardware market. It also lands as the company closes its fiscal second quarter on Dec. 31, setting up a fresh read on demand and delivery cadence when it next updates investors. Super Micro
1 January 2026
··
Goldman Sachs stock slips after hours as Wall Street ends 2025 lower; GS earnings in focus

Goldman Sachs stock slips after hours as Wall Street ends 2025 lower; GS earnings in focus

NEW YORK, December 31, 2025, 18:38 ET — After-hours Goldman Sachs Group Inc (GS) shares fell about 0.6% to $879 in after-hours trading on Wednesday, after trading between $876.75 and $886.26 during the regular session. About 1.2 million shares changed hands. The slide followed a modest year-end drop across U.S. equities as investors trimmed risk ahead of the New Year holiday. For Goldman, a bellwether for trading and dealmaking, attention is already shifting to January’s earnings season. Why it matters now: bank shares tend to react sharply when the outlook for interest rates changes. That is because rates influence loan
1 January 2026
·
1 … 1,050 1,051 1,052 1,053 1,054 … 2,715

Stock Market Today

Stellantis stock slides 24% after €22 billion EV reset kills 2026 dividend — what to watch next

Stellantis stock slides 24% after €22 billion EV reset kills 2026 dividend — what to watch next

7 February 2026
Stellantis shares plunged 23.7% to $7.28 Friday after the company disclosed about €22.2 billion in charges tied to a reset of its electric-vehicle strategy and said it will skip its 2026 dividend. The automaker flagged a preliminary net loss of €19–21 billion for the second half of 2025. Shares rose 1.6% in late after-hours trading. Investors await Feb. 26 results and a May 21 Investor Day.
Intel stock jumps on China server CPU delays as traders map the week ahead

Intel stock jumps on China server CPU delays as traders map the week ahead

7 February 2026
Intel shares rose 4.87% to $50.59 Friday, trailing gains by Nvidia and Broadcom as chip stocks rallied. Sources said Intel and AMD warned Chinese customers of longer waits and higher prices for some server CPUs, with Intel lead times reaching six months. Intel said China accounts for over 20% of its revenue. Investors await key U.S. jobs and inflation data next week.
IRS tax refund delays? Watchdog flags staffing crunch as 2026 filing season ramps up

IRS tax refund delays? Watchdog flags staffing crunch as 2026 filing season ramps up

7 February 2026
IRS staffing has dropped to 2021 levels as the 2026 tax filing season begins, according to a Treasury watchdog. The agency faces a backlog of about 2 million returns, 129% above pre-pandemic levels. Most e-filers using direct deposit still get refunds within 21 days, but paper filings and amended returns could see delays. The IRS lowered its call-answer target to 70% for this season.
Plug Power stock jumps 12% after vote setback, with Feb 17 share decision in focus

Plug Power stock jumps 12% after vote setback, with Feb 17 share decision in focus

7 February 2026
Plug Power shares rose 11.6% Friday to $2.08 after a sharp drop the previous day, as attention shifted to a Feb. 17 shareholder vote on expanding authorized shares. The company failed to secure enough votes earlier this week and is urging overseas holders to participate. CEO Andy Marsh cited difficulties for European investors in casting ballots. A reverse stock split remains possible if the proposal fails.
Go toTop